The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMs Intl. Regulatory News (MSI)

Share Price Information for Ms Intl. (MSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 910.00
Bid: 900.00
Ask: 920.00
Change: 0.00 (0.00%)
Spread: 20.00 (2.222%)
Open: 910.00
High: 910.00
Low: 910.00
Prev. Close: 910.00
MSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

17 Jun 2009 07:00

RNS Number : 0084U
MS International PLC
17 June 2009
 



Chairman's Statement

Results and review

If ever there was a time that truly heralded the virtues of operating a contemporary diverse engineering group, this is it. The significant growth from our Defence division almost totally compensated for the negative impact that some four months of intensifying global recession inflicted on our two Industrial Engineering divisions - forgings and petrol station forecourt structures. This impressive achievement by 'Defence' not only enabled the Group to report a reasonably robust set of results against a backdrop of deteriorating economic conditions but also elevated 'Defence' to become the major constituent part of the Group, accounting for half of total revenue.

For the year ended 2 May 2009, Group profit before taxation amounted to £4.92m (2008-£5.29m) on revenue of £51.56m (2008-£53.86m). Earnings per share were 19.5p (2008-22.0p).

Net cash and short term deposits at the year-end remained positive and amounted to £8.23m (2008-£10.07m).

I highlighted the significant gains being achieved by 'Defence' in my interim statement and I am pleased to report that it continued to perform strongly in the second half with resulting full year revenue up by some 25% compared to the previous year, mainly reflecting higher sales to overseas naval end-users and shipbuilders.

This uplift in both revenue and profit from 'Defence' was particularly important at a time when 'Industrial Engineering' encountered the real severity of the global slowdown during the second half of the year. 'Industrial Engineering' order intake declined steeply in the second half of the year amid low industrial activity, market weakness and immense uncertainty. The effects spread progressively through the individual businesses and by the final quarter 'Industrial Engineering' was contending with austere trading conditions.

However, as part of our corporate risk assessment review earlier in the year, we had already determined that any reduction in customer demand in our specific markets throughout the world was the principal risk issue for the Group, most pertinent for 'Industrial Engineering' which operates on short lead time order books. Accordingly we were prepared to implement immediate and appropriate counter-measures in a timely manner to re-align costs with the sharp reduction in demand.

Whilst the eventuality was disappointing and seriously undermined our plans to take advantage of the many efficiency gains that were being attained, our long and well established in-house training, routines and investment programmes aimed at improving our effectiveness have continued unabated, with greater commitment and application from everyone.

Outlook

Clearly there is considerable value in the contribution that 'Defence' affords our diverse Group, bestowing growth, a long term order book and excellent cash flow visibility, especially in these recessionary and unpredictable times.

Substantial 'Defence' orders in hand at the year end have been boosted further lately, and amongst others, we have been awarded a four year contract by the UK Ministry of Defence to provide contractor logistic support, fleet wide, for their in-service MSI-DS 30mm naval gun systems. Elsewhere, in the global defence equipment market, we are encouraged by the number of very interesting opportunities that exist for us to win additional business. 

Predicting how long 'Industrial Engineering' may have to endure depressed demand is difficult. Recovery may depend more upon there being a fundamental global spending upswing than any advantages purported to be offered by the perception of any sterling weakness. Notwithstanding, the Group has retained market share in the various markets that we serve and numerous opportunities to expand our positions are being exploited with a marked enthusiasm. The preservation of our broad spectrum of niche capabilities is important and currently any under-utilised plant and equipment is under a strict regime of upgrade/maintenance and care, but ready to be re-commissioned the instant there is an upturn anywhere in activity.

The positive counterbalance provided by 'Defence' should grant an element of protection to the Group until the economy and the global industrial engineering market sector in particular, recovers. Moreover, the Group will continue to benefit from being debt free and committed to the strategic importance of tight control of cash and working capital.

We will remain vigilant, focused on making positive, constructive decisions and taking actions to sharpen our operations and ensure that we are moving in the right direction, in order that we may position the Group to achieve long term success and profitable development once an economic recovery becomes firmly established. 

  

The record of progressive growth for the Group may have stalled temporarily, but we have the confidence, experience and resources that will assist us to withstand the present difficulties.

Undoubtedly, future results will depend upon the degree and duration of this recession and whilst we are hopeful of an upturn, we are not anticipating that it will happen in the short term, so we are planning our business strategy based upon a continuing difficult market in the year ahead.

Accordingly, the Board recommends the payment of a maintained final dividend of 3.80p (2008 - 3.80p) making a total for the year of 4.50p (2008 - 4.50p).

Michael Bell

16 June 2009

  

Group income statement

For the 52 weeks ended 2nd May, 2009

 

 

 

2009

2008

Total

Total

£000

£000

Revenue

51,559 

53,861 

Cost of sales

(39,139)

(40,393)

 

 

 

 

 

 

Gross profit

12,420 

13,468 

Distribution costs

(1,665)

 

(1,781)

Administrative expenses

 

(6,442)

(7,184)

 

 

(8,107)

(8,965)

 

 

 

 

 

 

Group trading profit

4,313 

4,503 

Finance revenue

142 

 

308 

Finance costs

 

(6)

 

(8)

Other finance revenue - pensions

470 

 

485 

606 

785 

 

 

 

 

 

 

Profit before taxation

4,919 

5,288 

Taxation

(1,401)

(1,355)

 

 

 

 

 

 

Profit for the period attributable to equity holders of the parent

3,518 

3,933 

 

 

 

 

 

 

 

Earnings per share: basic 

19.5p

22.0p

diluted

18.9p

21.5p

 

 

 

 

 

 

 

Group statement of recognised income and expense

For the 52 weeks ended 2nd May, 2009

Group

Company

2009

2008

2009

2008

Total

Total

Total

Total

£000

£000

£000

£000

Actuarial (losses)/gains on defined benefit pension scheme

(5,511)

548 

(5,511)

548 

Current taxation on actuarial (losses)/gains on defined benefit pension scheme

106

-

106

-

Deferred taxation on actuarial (losses)/gains on defined benefit pension scheme

1,437 

(127)

1,437 

(127)

Exchange differences on retranslation of foreign operations

158 

120 

- 

- 

 

 

 

 

 

Net (expense)/income recognised directly in equity

(3,810)

541 

(3,968)

421 

Profit attributable to equity holders of the parent

3,518 

3,933 

3,453 

3,769 

 

 

 

 

 

Total recognised income and expense for the period attributable to equity holders of the parent

(292)

4,474 

(515)

4,190 

 

 

 

 

 

The financial information set out above does not constitute the Company's statutory accounts for the periods ended 2nd May, 2009 or 3rd May, 2008 but is derived from those accounts. Statutory accounts for 2008 have been delivered to the Registrar of Companies, and those for 2009 will be delivered following the Company's Annual General Meeting. The auditors have reported on those accounts; their reports were unqualified and did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

The earnings per share is calculated by dividing the profit after taxation of £3,518,000 (2008 - £3,933,000) by the weighted average of 18,020,015 (2008 - 17,845,762) shares in issue in the year.

Copies of this announcement are available from the Company's registered office at MS INTERNATIONAL plc, Balby Carr Bank, DoncasterDN4 8DHEngland. The full Annual Report and Accounts will be posted to shareholders shortly and will be delivered to the Registrar of Companies after it has been laid before the Company in general meeting.

Dividend warrants will be posted on 31st July 2009 to members on the books of the Company at 3rd July, 2009.

  

Balance sheets

At 2nd May, 2009

Group

Company

2009

2008

2009

2008

£'000

£'000

£'000

£'000

ASSETS

Non-current assets

Property, plant and equipment

15,810 

16,101 

15,103 

15,269 

Intangible assets

106 

138 

106 

138 

Investments in subsidiaries

 -

 -

6,869 

6,869 

Investment in joint venture

 -

 -

50 

50 

Defined benefit pension asset

 -

1,856 

 -

1,856 

 

 

 

 

 

15,916 

18,095 

22,128 

24,182 

 

 

 

 

 

Current assets

Inventories

3,989 

5,104 

3,242 

3,779 

Trade and other receivables

5,712 

7,574 

5,594 

6,970 

Prepayments

1,600 

2,925 

1,528 

2,846 

Cash and short-term deposits

8,234 

10,071 

7,027 

9,209 

 

 

 

 

 

19,535 

25,674 

17,391 

22,804 

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

35,451 

43,769 

39,519 

46,986 

 

 

 

 

 

 

EQUITY AND LIABILITIES

Equity

Equity share capital

1,840 

1,845 

1,840 

1,845 

Capital redemption reserve

901 

896 

901 

896 

Other reserve

1,565 

1,565 

1,565 

1,565 

Revaluation reserve

2,969 

2,969 

2,969 

2,969 

Special reserve

1,629 

1,629 

1,629 

1,629 

Currency translation reserve

127 

(31)

-  

-

Treasury shares

(391)

(391)

(391)

(391)

Retained earnings

10,860 

12,131 

8,911 

10,247 

 

 

 

 

 

19,500 

20,613 

17,424 

18,760 

 

 

 

 

 

Non-current liabilities

Defined benefit pension liability

2,805 

 -

2,805 

 -

Government grants

16 

16 

Deferred income tax liability

610 

1,941 

617 

1,920 

 

 

 

 

 

3,418 

1,957 

3,425 

1,936 

 

 

 

 

 

Current liabilities

Trade and other payables

11,977 

20,606 

17,951 

25,754 

Finance leases

 -

 -

 -

Government grants

13 

13 

13 

13 

Income tax payable

543 

576 

706 

523 

 

 

 

 

 

12,533 

21,199 

18,670 

26,290 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL EQUITY AND LIABILITIES

35,451 

43,769 

39,519 

46,986 

 

 

 

 

 

 

  

Cash flow statements

For the 52 weeks ended 2nd May, 2009

Group

Company

2009

2008

2009

2008

£000

£000

£000

£000

Trading profit

4,313 

4,503 

3,850 

3,442 

Adjustments to reconcile trading profit to net cash in flow from operating activities

Depreciation charge 

1,704 

1,412 

1,463 

1,169 

Amortisation charge

79 

115 

79 

115 

Diminution in value of subsidiaries

-

-

(1)

Foreign exchange gains

146 

37 

95 

106 

RSA grant release

(13)

(12)

(13)

(12)

Share based payments

90 

205 

90 

205 

Decrease/(increase) in inventories

1,342 

(555)

556 

(57)

Decrease/(increase) in receivables

1,862 

(286)

1,376 

(96)

Decrease/(increase) in prepayments

1,325 

(816)

1,318 

(821)

(Decrease)/increase in payables

(3,332)

771 

(2,719)

600 

(Decrease)/increase in progress payments

(5,524)

1,553 

(5,103)

1,150 

Provisions utilised

-

(113)

-

(113)

Pension fund

(380)

71 

(380)

71 

 

 

 

 

 

Cash generated from operating activities

1,612 

6,885 

611 

5,761 

Interest received

136 

300 

126 

277 

Taxation paid

(1,219)

(1,165)

(914)

(812)

 

 

 

 

 

Net cash inflow/(outflow) from operating activities

529 

6,020 

(177)

5,226 

Investing activities

Purchase of property , plant and equipment

(1,506)

(2,838)

(1,397)

(2,687)

Purchase of intangible assets

(47)

-

(47)

 

-

Sale of property, plant and equipment

102 

 

88 

 

100 

 

86 

Dividends received from joint venture

-

 

-

 

250 

 

500 

 

 

 

 

 

 

 

 

 

Net cash from investing activities

(1,451)

(2,750)

(1,094)

(2,101)

Financing activities

Purchase of own shares

-

(308)

-

 

(308)

Repurchase of shares

(99)

(477)

 

(99)

 

(477)

Share options exercised

-

 

655 

 

-

 

655 

Dividends paid

(812)

 

(670)

 

(812)

(670)

Repayments of capital element of finance leases

(4)

(7)

-

 

-

Net cash flow from financing activities

(915)

(807)

(911)

(800)

 

 

 

 

 

 

 

 

(Decrease)/increase in cash and cash equivalents

(1,837)

2,463 

(2,182)

2,325 

Opening cash and cash equivalents

10,071 

7,608 

9,209 

6,884 

 

 

 

 

 

Closing cash and cash equivalents

8,234 

10,071 

7,027 

9,209 

 

 

 

 

 

Reconciliation of movement in equity

Capital

Currency

Issued

redemption

Other

Revaluation

Special

translation

Treasury

Retained

capital

reserve

reserve

reserve

reserve

reserve

shares

earnings

Total

£000

£000

£000

£000

£000

£000

£000

£000

£000

(a) Group

At 28th April, 2007

1,871

870

1,544

2,942

1,629

(151) 

(738) 

8,719

16,686

Total recognised income and expense for the year

-

-

-

-

-

120

-

4,354

4,474

Dividends paid

-

-

-

-

-

-

-

(670) 

(670) 

Repurchase of shares 

(26) 

26

-

-

-

-

-

(477) 

(477) 

Change in taxation rate

-

-

21

27

-

-

-

-

48

Share options

-

-

-

-

-

-

205

205

Exercise of share options

-

-

-

-

-

-

655

-

655

Purchase of own shares

-

-

-

-

-

-

(308) 

-

(308) 

 

 

 

 

 

 

 

 

 

 

 

At 3rd May, 2008

1,845

896

1,565

2,969

1,629

(31) 

(391) 

12,131

20,613

Total recognised income and expense for the year

-

-

-

-

-

158

-

(450) 

(292) 

Dividends paid

-

-

-

-

-

-

-

(812) 

(812) 

Repurchase of shares 

(5) 

5

-

-

-

-

-

(99) 

(99) 

Share options

-

-

-

-

-

-

-

90

90

 

 

 

 

 

 

 

 

 

 

 

At 2nd May, 2009

1,840 

901 

1,565 

2,969 

1,629 

127 

(391)

10,860 

19,500

 

 

 

 

 

 

 

 

 

 

 

(b) Company

At 28th April, 2007

1,871

870

1,544

2,942

1,629

- 

(738) 

6,999

15,117

Total recognised income and expense for the year

-

-

-

-

-

-

-

4,190

4,190

Dividends paid

-

-

-

-

-

-

-

(670) 

(670) 

Repurchase of shares 

(26) 

26

-

-

-

-

(477) 

(477) 

Change in taxation rate

-

-

21

27

-

-

-

-

48

Share options

-

-

-

-

-

-

-

205

205

Exercise of share options

-

-

-

-

-

-

655

-

655

Purchase of own shares

-

-

-

-

-

-

(308) 

-

(308) 

 

 

 

 

 

 

 

 

 

 

 

At 3rd May, 2008

1,845

896

1,565

2,969

1,629

- 

(391) 

10,247

18,760

Total recognised income and expense for the year

-

-

-

-

-

-

-

(515

(515) 

Dividends paid

-

-

-

-

-

-

-

(812) 

(812) 

Repurchase of shares 

(5) 

5

-

-

-

-

-

(99) 

(99) 

Share options

-

-

-

-

-

-

-

90

90

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At 2nd May, 2009

1,840 

901 

1,565 

2,969 

1,629 

- 

(391)

8,911 

17,424 

 

 

 

 

 

 

 

 

 

 

 

(1)

Share Capital

The balance classified as share capital includes the nominal value on issue of the Company's equity share capital, comprising 10p Ordinary shares.

(2)

Capital redemption reserve

The balance classified as capital redemption reserve represents the nominal value of issued share capital of the Company, repurchased.

  

(3)

Other reserve

This is the revaluation reserve previously arising under UK GAAP which is now part of non-distributable retained reserves. This also includes the impact of the change in related deferred tax due to the change in corporation tax (30% to 28%).

(4)

Revaluation reserve

The asset revaluation reserve is used to record increases in the fair value of land and buildings and decreases to the extent that such decrease relates to an increase on the same assets previously recognised in equity. This also includes the impact of the change in related deferred tax due to the change in corporation tax (30% to 28%).

(5)

Special reserve

The balance classified as special reserve represents the share premium on the issue of the Company's equity share capital.

(6)

Currency translation reserve

The foreign currency translation reserve is used to record exchange differences arising from the translation of the financial statements of foreign subsidiaries. It is also used to record the effect of hedging net investments in foreign operations.

(7)

Treasury Shares

During 1991 the Company established an Employee Share Ownership Trust ("ESOT"). The trustee of the ESOT is Appleby Trust (Jersey) Ltd, an independent company registered in Jersey. The ESOT provides for the issue of options over Ordinary shares in the Company to Group employees, including executive directors, at the discretion of the Remuneration Committee.

The trust has purchased an aggregate 395,048 Ordinary shares, which represents 2.1% of the issued share capital of the Company at an aggregate cost of £391,000. The market value of the shares at 2nd May, 2009 was £401,000. The Company has made payments of £Nil (2008 - £Nil) into the ESOT bank accounts during the period. No options over shares (2008 - 374,000) have been granted during the period. Details of the outstanding share options for Directors are included in the Directors' Remuneration Report.

The assets, liabilities, income and costs of the ESOT have been incorporated into the Company's financial statements. Total ESOT costs charged to the income statement in the period amounts to £3,000 (2008 - £9,000). During the period no options were exercised (2008 - 1,912,521) and no shares were purchased (2008 - 153,500).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR FFMFTMMABBAL
Date   Source Headline
30th Apr 20244:06 pmRNSHolding(s) in Company
30th Jan 20244:06 pmRNSDirector/PDMR Shareholding
9th Jan 20243:04 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSHalf-year Report
6th Nov 20231:17 pmRNSDirector/PDMR Shareholding
2nd Nov 20234:06 pmRNSGrant of Awards and Director/PDMR Shareholding
20th Oct 202312:49 pmRNSDirector/PDMR Shareholding
19th Oct 20231:50 pmRNSHolding(s) in Company - Replacement
19th Oct 202311:19 amRNSHolding(s) in Company
17th Oct 202311:48 amRNSDirector/PDMR Shareholding
16th Oct 20233:45 pmRNSDirector/PDMR Shareholding
10th Oct 202311:51 amRNSDirector/PDMR Shareholding
2nd Oct 202311:10 amRNSContract For Electro-Optical Sight Systems
29th Sep 20238:20 amRNSSupply of MSI-DS 30mm Gun Mounts to US Navy
14th Sep 20231:34 pmRNSTotal Voting Rights
5th Sep 20234:16 pmRNSHolding(s) in Company
1st Sep 20231:44 pmRNSContract to Maintain MSI-DS 30mm Weapon System
10th Aug 20231:07 pmRNSResult of AGM
18th Jul 20232:32 pmRNSTotal Voting Rights
10th Jul 20232:49 pmRNSHolding(s) in Company
7th Jul 202311:29 amRNSPurchase of Own Shares
5th Jul 20232:00 pmRNSExercise of Options and Total Voting Rights
4th Jul 20232:25 pmRNSExercise of Options and Director/PDMR Shareholding
28th Jun 20231:38 pmRNSShare Options and Director/PDMR Shareholding
27th Jun 20233:49 pmRNSHolding(s) in Company
23rd Jun 20232:46 pmRNSShare Options, Dividend Timetable & Director/PDMR
22nd Jun 20237:00 amRNSAnnual Financial Report
15th Feb 20231:47 pmRNSDirector/PDMR Shareholding
2nd Feb 202311:40 amRNSDirector/PDMR Shareholding
3rd Jan 20231:27 pmRNSTotal Voting Rights
23rd Dec 20227:00 amRNSFirst Sales of New Land Based Mobile Gun System
13th Dec 20222:26 pmRNSDirector/PDMR Shareholding & Total Voting Rights
7th Dec 20227:00 amRNSHalf-year Report
12th Oct 202212:17 pmRNSDirector/PDMR Shareholding
29th Sep 20221:48 pmRNSDirector/PDMR Shareholding
22nd Sep 20221:00 pmRNSDirector/PDMR Shareholding
13th Sep 202212:11 pmRNSDirector/PDMR Shareholding
9th Sep 20222:36 pmRNSDirector/PDMR Shareholding - Replacement
9th Sep 20221:00 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSResult of AGM
28th Jun 20227:26 amRNSAnnual Financial Report
27th Apr 202211:08 amRNSDirector/PDMR Shareholding
26th Apr 202211:32 amRNSDirector/PDMR Shareholding
19th Apr 20223:29 pmRNSDirector/PDMR Shareholding
6th Apr 20222:38 pmRNSDirector/PDMR Shareholding
20th Jan 202210:08 amRNSDirector/PDMR Shareholding
8th Dec 20217:00 amRNSHalf-year Report
3rd Aug 202110:39 amRNSCompany Secretary Change
29th Jul 20214:06 pmRNSResult of AGM
7th Jul 202111:32 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.